> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Approves Teligent’s ANDA for Topical Erythromycin
- URL: https://www.fdaweb.com/fda-approves-teligents-anda-for-topical-erythromycin/
- Published: 2017-07-24T12:00:00.000Z
- Updated: 2026-09-14T22:35:58.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5139201

FDA has approved a Teligent ANDA for generic erythromycin topical gel, an antibiotic for treating skin infections. Based on recent QuintilesIMS Health data from 5/2017, the market for this product is about $17.6 million. Teligent has 19 topical generic pharmaceutical products in its U.S. portfolio.